{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T01:34:45Z","timestamp":1777253685342,"version":"3.51.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2024NSFSC1795"],"award-info":[{"award-number":["2024NSFSC1795"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2022NSFSC0828"],"award-info":[{"award-number":["2022NSFSC0828"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"name":"1\u00b73\u00b75 project for disciplines of excellence, West China Hospital, Sichuan University","award":["ZYGD23019"],"award-info":[{"award-number":["ZYGD23019"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-05727-7","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T04:42:31Z","timestamp":1773808951000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gender differences in asymptomatic hyperuricemia\u2019s effects on left ventricular function and remodeling in hypertension: insights from cardiac MRI"],"prefix":"10.1186","volume":"26","author":[{"given":"Wei-Feng","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-Qin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Ke","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Gang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"issue":"9932","key":"5727_CR1","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1016\/S0140-6736(14)60685-1","volume":"383","author":"E Rapsomaniki","year":"2014","unstructured":"Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah A, Denaxas S, White I, Caulfield M, Deanfield J, Smeeth L, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1\u00b725 million people. Lancet (London England). 2014;383(9932):1899\u2013911.","journal-title":"Lancet (London England)"},{"issue":"6","key":"5727_CR2","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1161\/HYPERTENSIONAHA.120.13896","volume":"75","author":"S Chakraborty","year":"2020","unstructured":"Chakraborty S, Mandal J, Yang T, Cheng X, Yeo J, McCarthy C, Wenceslau C, Koch L, Hill J, Vijay-Kumar M, et al. Metabolites and Hypertension: Insights into Hypertension as a Metabolic Disorder: 2019 Harriet Dustan Award. Hypertens (Dallas Tex: 1979). 2020;75(6):1386\u201396.","journal-title":"Hypertens (Dallas Tex: 1979)"},{"issue":"2","key":"5727_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41584-019-0334-3","volume":"16","author":"L Joosten","year":"2020","unstructured":"Joosten L, Cri\u015fan T, Bjornstad P, Johnson R. Asymptomatic hyperuricaemia: a silent activator of the innate immune system. Nat Rev Rheumatol. 2020;16(2):75\u201386.","journal-title":"Nat Rev Rheumatol"},{"key":"5727_CR4","doi-asserted-by":"publisher","first-page":"8815603","DOI":"10.1155\/2024\/8815603","volume":"2024","author":"T Feng","year":"2024","unstructured":"Feng T, Li C, Zheng J, Xu Y, Wang X, Li Y, Wang Y, Zhu B, Zhao L, Yu J. Prevalence of and Risk Factors for Hyperuricemia in Urban Chinese Check-Up Population. Int J Endocrinol. 2024;2024:8815603.","journal-title":"Int J Endocrinol"},{"issue":"1","key":"5727_CR5","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1186\/s12872-024-04055-y","volume":"24","author":"M Hussain","year":"2024","unstructured":"Hussain M, Ghori MU, Aslam MN, Abbas S, Shafique M, Awan FR. Serum uric acid: an independent risk factor for cardiovascular disease in Pakistani Punjabi patients. BMC Cardiovasc Disord. 2024;24(1):546.","journal-title":"BMC Cardiovasc Disord"},{"issue":"11","key":"5727_CR6","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/hr.2012.99","volume":"35","author":"T Kawai","year":"2012","unstructured":"Kawai T, Ohishi M, Takeya Y, Onishi M, Ito N, Yamamoto K, Kamide K, Rakugi H. Serum uric acid is an independent risk factor for cardiovascular disease and mortality in hypertensive patients. Hypertens research: official J Japanese Soc Hypertens. 2012;35(11):1087\u201392.","journal-title":"Hypertens research: official J Japanese Soc Hypertens"},{"issue":"1","key":"5727_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/eurjhf\/hft132","volume":"16","author":"H Huang","year":"2014","unstructured":"Huang H, Huang B, Li Y, Huang Y, Li J, Yao H, Jing X, Chen J, Wang J. Uric acid and risk of heart failure: a systematic review and meta-analysis. Eur J Heart Fail. 2014;16(1):15\u201324.","journal-title":"Eur J Heart Fail"},{"issue":"17","key":"5727_CR8","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMra0800885","volume":"359","author":"D Feig","year":"2008","unstructured":"Feig D, Kang D, Johnson R. Uric acid and cardiovascular risk. N Engl J Med. 2008;359(17):1811\u201321.","journal-title":"N Engl J Med"},{"issue":"1","key":"5727_CR9","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12933-023-02006-z","volume":"22","author":"M Perticone","year":"2023","unstructured":"Perticone M, Maio R, Shehaj E, Gigliotti S, Caroleo B, Suraci E, Sciacqua A, Andreozzi F, Perticone F. Sex-related differences for uric acid in the prediction of cardiovascular events in essential hypertension. A population prospective study. Cardiovasc Diabetol. 2023;22(1):298.","journal-title":"Cardiovasc Diabetol"},{"key":"5727_CR10","doi-asserted-by":"publisher","first-page":"1415459","DOI":"10.3389\/fendo.2024.1415459","volume":"15","author":"XY Chen","year":"2024","unstructured":"Chen XY, Lu F, Zhang J, Xu CX, Du XF, Liang MB, Chen LJ, Zhong JM. The effect of hyperuricemia and its interaction with hypertension towards chronic kidney disease in patients with type 2 diabetes: evidence from a cross- sectional study in Eastern China. Front Endocrinol (Lausanne). 2024;15:1415459.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"5727_CR11","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41371-022-00789-4","volume":"37","author":"Z Azizi","year":"2023","unstructured":"Azizi Z, Alipour P, Raparelli V, Norris CM, Pilote L. The role of sex and gender in hypertension. J Hum Hypertens. 2023;37(8):589\u201395.","journal-title":"J Hum Hypertens"},{"issue":"12","key":"5727_CR12","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.jcmg.2015.11.001","volume":"8","author":"P Claus","year":"2015","unstructured":"Claus P, Omar A, Pedrizzetti G, Sengupta P, Nagel E. Tissue Tracking Technology for Assessing Cardiac Mechanics: Principles, Normal Values, and Clinical Applications. JACC Cardiovasc imaging. 2015;8(12):1444\u201360.","journal-title":"JACC Cardiovasc imaging"},{"issue":"1","key":"5727_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40885-021-00186-y","volume":"28","author":"JK Oh","year":"2022","unstructured":"Oh JK, Park JH. Role of strain echocardiography in patients with hypertension. Clin Hypertens. 2022;28(1):6.","journal-title":"Clin Hypertens"},{"issue":"8","key":"5727_CR14","doi-asserted-by":"publisher","first-page":"5424","DOI":"10.1007\/s00330-022-08629-2","volume":"32","author":"J Xu","year":"2022","unstructured":"Xu J, Yang W, Zhao S, Lu M. State-of-the-art myocardial strain by CMR feature tracking: clinical applications and future perspectives. Eur Radiol. 2022;32(8):5424\u201335.","journal-title":"Eur Radiol"},{"issue":"20","key":"5727_CR15","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.4103\/0366-6999.216416","volume":"130","author":"Chinese Multidisciplinary Expert Consensus on the Diagnosis","year":"2017","unstructured":"Chinese Multidisciplinary Expert Consensus on the Diagnosis. Treatment of Hyperuricemia and Related Diseases. Chin Med J. 2017;130(20):2473\u201388.","journal-title":"Chin Med J"},{"issue":"4","key":"5727_CR16","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10741-017-9621-8","volume":"22","author":"A Scatteia","year":"2017","unstructured":"Scatteia A, Baritussio A, Bucciarelli-Ducci C. Strain imaging using cardiac magnetic resonance. Heart Fail Rev. 2017;22(4):465\u201376.","journal-title":"Heart Fail Rev"},{"issue":"1","key":"5727_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12933-023-01806-7","volume":"22","author":"R Shi","year":"2023","unstructured":"Shi R, Yang Z, Guo Y, Qian W, Gao Y, Li X, Jiang L, Xu H, Li Y. The right ventricular dysfunction and ventricular interdependence in patients with DM: assessment using cardiac MR feature tracking. Cardiovasc Diabetol. 2023;22(1):93.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"5727_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12968-020-00610-6","volume":"22","author":"J Schulz-Menger","year":"2020","unstructured":"Schulz-Menger J, Bluemke D, Bremerich J, Flamm S, Fogel M, Friedrich M, Kim R, von Knobelsdorff-Brenkenhoff F, Kramer C, Pennell D, et al. Standardized image interpretation and post-processing in cardiovascular magnetic resonance\u2009\u2013\u20092020 update: Society for Cardiovascular Magnetic Resonance (SCMR): Board of Trustees Task Force on Standardized Post-Processing. J Cardiovasc Magn resonance: official J Soc Cardiovasc Magn Reson. 2020;22(1):19.","journal-title":"J Cardiovasc Magn resonance: official J Soc Cardiovasc Magn Reson"},{"issue":"3","key":"5727_CR19","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1097\/HJH.0000000000002287","volume":"38","author":"E Casiglia","year":"2020","unstructured":"Casiglia E, Tikhonoff V, Virdis A, Masi S, Barbagallo C, Bombelli M, Bruno B, Cicero A, Cirillo M, Cirillo P, et al. Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study. J Hypertens. 2020;38(3):412\u20139.","journal-title":"J Hypertens"},{"issue":"1","key":"5727_CR20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13690-024-01421-2","volume":"82","author":"J Zhu","year":"2024","unstructured":"Zhu J, Shen L, Jia S, Wang W, Xiong Y. The role of uric acid in the risk of hypertension developed from prehypertension: a five-year Chinese urban cohort study. Arch Public Health. 2024;82(1):185.","journal-title":"Arch Public Health"},{"issue":"9","key":"5727_CR21","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1161\/HYPERTENSIONAHA.122.17956","volume":"79","author":"C Borghi","year":"2022","unstructured":"Borghi C, Agnoletti D, Cicero AFG, Lurbe E, Virdis A. Uric Acid and Hypertension: a Review of Evidence and Future Perspectives for the Management of Cardiovascular Risk. Hypertension. 2022;79(9):1927\u201336.","journal-title":"Hypertension"},{"issue":"5","key":"5727_CR22","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1161\/hy1101.092839","volume":"38","author":"M Mazzali","year":"2001","unstructured":"Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, Lan HY, Kivlighn S, Johnson RJ. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension. 2001;38(5):1101\u20136.","journal-title":"Hypertension"},{"issue":"6","key":"5727_CR23","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1161\/01.HYP.0000069700.62727.C5","volume":"41","author":"R Johnson","year":"2003","unstructured":"Johnson R, Kang D, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle K, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertens (Dallas Tex: 1979). 2003;41(6):1183\u201390.","journal-title":"Hypertens (Dallas Tex: 1979)"},{"key":"5727_CR24","doi-asserted-by":"crossref","unstructured":"Mancusi C, Izzo R, Ferrara L, Rozza F, Losi M, Canciello G, Pepe M, de Luca N, Trimarco B, de Simone G. Is increased uric acid a risk factor or a defensive response? The Campania Salute Network. Nutrition, metabolism, and cardiovascular diseases: NMCD. 2018;28(8):839\u2013846.","DOI":"10.1016\/j.numecd.2018.04.013"},{"issue":"10","key":"5727_CR25","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1097\/HJH.0000000000002898","volume":"39","author":"M Tadic","year":"2021","unstructured":"Tadic M, Sala C, Carugo S, Mancia G, Grassi G, Cuspidi C. Myocardial strain in hypertension: a meta-analysis of two-dimensional speckle tracking echocardiographic studies. J Hypertens. 2021;39(10):2103\u201312.","journal-title":"J Hypertens"},{"issue":"9","key":"5727_CR26","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1097\/HJH.0000000000001396","volume":"35","author":"P Perrone-Filardi","year":"2017","unstructured":"Perrone-Filardi P, Coca A, Galderisi M, Paolillo S, Alpendurada F, de Simone G, Donal E, Kahan T, Mancia G, Redon J, et al. Noninvasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: a consensus article from the European Association of Cardiovascular Imaging, the European Society of Cardiology Council on Hypertension and the European Society of Hypertension. J Hypertens. 2017;35(9):1727\u201341.","journal-title":"J Hypertens"},{"issue":"11","key":"5727_CR27","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1681\/ASN.2014070660","volume":"26","author":"M Kleber","year":"2015","unstructured":"Kleber M, Delgado G, Grammer T, Silbernagel G, Huang J, Kr\u00e4mer B, Ritz E, M\u00e4rz W. Uric Acid and Cardiovascular Events: A Mendelian Randomization Study. J Am Soc Nephrology: JASN. 2015;26(11):2831\u20138.","journal-title":"J Am Soc Nephrology: JASN"},{"issue":"6","key":"5727_CR28","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1161\/HYPERTENSIONAHA.116.08998","volume":"69","author":"M Kuwabara","year":"2017","unstructured":"Kuwabara M, Niwa K, Hisatome I, Nakagawa T, Roncal-Jimenez C, Andres-Hernando A, Bjornstad P, Jensen T, Sato Y, Milagres T, et al. Asymptomatic Hyperuricemia Without Comorbidities Predicts Cardiometabolic Diseases: Five-Year Japanese Cohort Study. Hypertens (Dallas Tex: 1979). 2017;69(6):1036\u201344.","journal-title":"Hypertens (Dallas Tex: 1979)"},{"issue":"33","key":"5727_CR29","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement D, Coca A, de Simone G, Dominiczak A, et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021\u2013104.","journal-title":"Eur Heart J"},{"issue":"6","key":"5727_CR30","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/art.41247","volume":"72","author":"J FitzGerald","year":"2020","unstructured":"FitzGerald J, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles A, Gelber A, Harrold L, Khanna D, King C, et al. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Rheumatol (Hoboken NJ). 2020;72(6):879\u201395.","journal-title":"Arthritis Rheumatol (Hoboken NJ)"},{"key":"5727_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4137\/CMC.S38407","volume":"10","author":"AM Ayoub","year":"2016","unstructured":"Ayoub AM, Keddeas VW, Ali YA, El Okl RA. Subclinical LV Dysfunction Detection Using Speckle Tracking Echocardiography in Hypertensive Patients with Preserved LV Ejection Fraction. Clin Med Insights Cardiol. 2016;10:85\u201390.","journal-title":"Clin Med Insights Cardiol"},{"issue":"1","key":"5727_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12968-020-00636-w","volume":"22","author":"H Ito","year":"2020","unstructured":"Ito H, Ishida M, Makino W, Goto Y, Ichikawa Y, Kitagawa K, Omori T, Dohi K, Ito M, Sakuma H. Cardiovascular magnetic resonance feature tracking for characterization of patients with heart failure with preserved ejection fraction: correlation of global longitudinal strain with invasive diastolic functional indices. J Cardiovasc Magn resonance: official J Soc Cardiovasc Magn Reson. 2020;22(1):42.","journal-title":"J Cardiovasc Magn resonance: official J Soc Cardiovasc Magn Reson"},{"issue":"8","key":"5727_CR33","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.jacc.2017.06.046","volume":"70","author":"T Stokke","year":"2017","unstructured":"Stokke T, Hasselberg N, Smedsrud M, Sarvari S, Haugaa K, Smiseth O, Edvardsen T, Remme E. Geometry as a Confounder When Assessing Ventricular Systolic Function: Comparison Between Ejection Fraction and Strain. J Am Coll Cardiol. 2017;70(8):942\u201354.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"5727_CR34","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.113.02149","volume":"63","author":"T Ishizu","year":"2014","unstructured":"Ishizu T, Seo Y, Kameda Y, Kawamura R, Kimura T, Shimojo N, Xu D, Murakoshi N, Aonuma K. Left ventricular strain and transmural distribution of structural remodeling in hypertensive heart disease. Hypertens (Dallas Tex: 1979). 2014;63(3):500\u20136.","journal-title":"Hypertens (Dallas Tex: 1979)"},{"issue":"10","key":"5727_CR35","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1016\/j.numecd.2021.06.012","volume":"31","author":"JH Liu","year":"2021","unstructured":"Liu JH, Wu MZ, Li SM, Chen Y, Ren QW, Lin QS, Ng MY, Tse HF, Yiu KH. Association of serum uric acid with biventricular myocardial dysfunction in patients with type 2 diabetes mellitus. Nutr metabolism Cardiovasc diseases: NMCD. 2021;31(10):2912\u201320.","journal-title":"Nutr metabolism Cardiovasc diseases: NMCD"},{"issue":"1","key":"5727_CR36","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12933-021-01310-w","volume":"20","author":"L La Sala","year":"2021","unstructured":"La Sala L, Tagliabue E, Vieira E, Pontiroli A, Folli F. High plasma renin activity associates with obesity-related diabetes and arterial hypertension, and predicts persistent hypertension after bariatric surgery. Cardiovasc Diabetol. 2021;20(1):118.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"5727_CR37","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1161\/HYPERTENSIONAHA.118.11125","volume":"72","author":"A Gonz\u00e1lez","year":"2018","unstructured":"Gonz\u00e1lez A, Ravassa S, L\u00f3pez B, Moreno M, Beaumont J, San Jos\u00e9 G, Querejeta R, Bay\u00e9s-Gen\u00eds A, D\u00edez J. Myocardial Remodeling in Hypertension. Hypertens (Dallas Tex: 1979). 2018;72(3):549\u201358.","journal-title":"Hypertens (Dallas Tex: 1979)"},{"issue":"1","key":"5727_CR38","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12933-022-01551-3","volume":"21","author":"J Li","year":"2022","unstructured":"Li J, Liu H, Li S. Landscape of cardiometabolic risk factors in Chinese population: a narrative review. Cardiovasc Diabetol. 2022;21(1):113.","journal-title":"Cardiovasc Diabetol"},{"key":"5727_CR39","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12933-016-0409-2","volume":"15","author":"J Oyama","year":"2016","unstructured":"Oyama J, Tanaka A, Sato Y, Tomiyama H, Sata M, Ishizu T, Taguchi I, Kuroyanagi T, Teragawa H, Ishizaka N, et al. Rationale and design of a multicenter randomized study for evaluating vascular function under uric acid control using the xanthine oxidase inhibitor, febuxostat: the PRIZE study. Cardiovasc Diabetol. 2016;15:87.","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"5727_CR40","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1097\/HJH.0000000000002189","volume":"37","author":"C Gingles","year":"2019","unstructured":"Gingles C, Symon R, Gandy S, Struthers A, Houston G, MacDonald T, Lang C, Donnan P, George J. Allopurinol treatment adversely impacts left ventricular mass regression in patients with well-controlled hypertension. J Hypertens. 2019;37(12):2481\u20139.","journal-title":"J Hypertens"},{"issue":"5","key":"5727_CR41","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.kint.2020.05.056","volume":"98","author":"C Ponticelli","year":"2020","unstructured":"Ponticelli C, Podest\u00e0 M, Moroni G. Hyperuricemia as a trigger of immune response in hypertension and chronic kidney disease. Kidney Int. 2020;98(5):1149\u201359.","journal-title":"Kidney Int"},{"issue":"1","key":"5727_CR42","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/HJH.0000000000003564","volume":"42","author":"E Gherbesi","year":"2024","unstructured":"Gherbesi E, Faggiano A, Sala C, Carugo S, Grassi G, Tadic M, Cuspidi C. Uric acid and left ventricular hypertrophy: a gender-based meta-analysis of echocardiographic studies. J Hypertens. 2024;42(1):109\u201317.","journal-title":"J Hypertens"},{"issue":"2","key":"5727_CR43","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1291\/hypres.28.133","volume":"28","author":"A Kurata","year":"2005","unstructured":"Kurata A, Shigematsu Y, Higaki J. Sex-related differences in relations of uric acid to left ventricular hypertrophy and remodeling in Japanese hypertensive patients. Hypertens research: official J Japanese Soc Hypertens. 2005;28(2):133\u20139.","journal-title":"Hypertens research: official J Japanese Soc Hypertens"},{"issue":"1","key":"5727_CR44","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1536\/ihj.13-170","volume":"55","author":"A Yoshimura","year":"2014","unstructured":"Yoshimura A, Adachi H, Hirai Y, Enomoto M, Fukami A, Kumagai E, Ohbu K, Nakamura S, Obuchi A, Nohara Y, et al. Serum uric acid is associated with the left ventricular mass index in males of a general population. Int Heart J. 2014;55(1):65\u201370.","journal-title":"Int Heart J"},{"issue":"1","key":"5727_CR45","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12872-018-0989-8","volume":"19","author":"V Stubnova","year":"2019","unstructured":"Stubnova V, Os I, H\u00f8ieggen A, Solbu M, Grundtvig M, Westheim A, Atar D, Waldum-Grevbo B. Gender differences in association between uric acid and all-cause mortality in patients with chronic heart failure. BMC Cardiovasc Disord. 2019;19(1):4.","journal-title":"BMC Cardiovasc Disord"},{"issue":"3","key":"5727_CR46","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1080\/00365513.2019.1576098","volume":"79","author":"T Kerola","year":"2019","unstructured":"Kerola T, Kauppi J, Sares-J\u00e4ske L, Anttonen O, Junttila M, Huikuri H, Nieminen T, Rissanen H, Heli\u00f6vaara M, Kauppi M, et al. Long-term prognostic impact of hyperuricemia in community. Scand J Clin Lab Investig. 2019;79(3):148\u201353.","journal-title":"Scand J Clin Lab Investig"},{"issue":"5","key":"5727_CR47","doi-asserted-by":"publisher","first-page":"H986","DOI":"10.1152\/ajpheart.00402.2015","volume":"309","author":"S Nogi","year":"2015","unstructured":"Nogi S, Fujita S, Okamoto Y, Kizawa S, Morita H, Ito T, Sakane K, Sohmiya K, Hoshiga M, Ishizaka N. Serum uric acid is associated with cardiac diastolic dysfunction among women with preserved ejection fraction. Am J Physiol Heart Circ Physiol. 2015;309(5):H986\u2013994.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"5727_CR48","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/s41440-023-01535-0","volume":"47","author":"AA Salim","year":"2024","unstructured":"Salim AA, Kawasoe S, Kubozono T, Ojima S, Kawabata T, Ikeda Y, Miyahara H, Tokushige K, Ohishi M. Sex-specific associations between serum uric acid levels and risk of hypertension for different diagnostic reference values of high blood pressure. Hypertens research: official J Japanese Soc Hypertens. 2024;47(5):1120\u201332.","journal-title":"Hypertens research: official J Japanese Soc Hypertens"},{"issue":"1","key":"5727_CR49","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12933-024-02214-1","volume":"23","author":"K Fu","year":"2024","unstructured":"Fu K, Cheng C, Su C, Teng J, Qiao L, Xiao J, Ji X, Lu H, Chen W. Gender differences in the relationship between serum uric acid and the long-term prognosis in heart failure: a nationwide study. Cardiovasc Diabetol. 2024;23(1):131.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"5727_CR50","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12986-021-00583-y","volume":"18","author":"L Liu","year":"2021","unstructured":"Liu L, Zhao T, Shan L, Cao L, Zhu X, Xue Y. Estradiol regulates intestinal ABCG2 to promote urate excretion via the PI3K\/Akt pathway. Nutr metabolism. 2021;18(1):63.","journal-title":"Nutr metabolism"},{"issue":"5","key":"5727_CR51","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/jcmm.13038","volume":"21","author":"MC Kander","year":"2017","unstructured":"Kander MC, Cui Y, Liu Z. Gender difference in oxidative stress: a new look at the mechanisms for cardiovascular diseases. J Cell Mol Med. 2017;21(5):1024\u201332.","journal-title":"J Cell Mol Med"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-05727-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05727-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05727-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T01:02:34Z","timestamp":1777251754000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-05727-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5727"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-05727-7","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. Ethics approval was obtained from the Ethics Committee on Biomedical Research, West China Hospital of Sichuan University (Approval No. 2019\u2009\u2212\u2009811). Written informed consent was waived owing to the retrospective design and prior anonymisation of data, in line with the Chinese\n                      Measures for Ethical Review of Biomedical Research Involving Humans\n                      .","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"355"}}